| American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism TL Ortel, I Neumann, W Ageno, R Beyth, NP Clark, A Cuker, BA Hutten, ... Blood advances 4 (19), 4693-4738, 2020 | 1124 | 2020 |
| Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum GD Barnes, A Burnett, A Allen, M Blumenstein, NP Clark, A Cuker, ... Journal of thrombosis and thrombolysis 50, 72-81, 2020 | 609 | 2020 |
| American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy DM Witt, R Nieuwlaat, NP Clark, J Ansell, A Holbrook, J Skov, N Shehab, ... Blood advances 2 (22), 3257-3291, 2018 | 552 | 2018 |
| Perioperative management of patients with atrial fibrillation receiving a direct oral anticoagulant JD Douketis, AC Spyropoulos, J Duncan, M Carrier, G Le Gal, AJ Tafur, ... JAMA internal medicine 179 (11), 1469-1478, 2019 | 456 | 2019 |
| Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists F Dentali, C Marchesi, MG Pierfranceschi, M Crowther, D Garcia, E Hylek, ... Thrombosis and haemostasis 106 (09), 429-438, 2011 | 384 | 2011 |
| Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for gastrointestinal tract bleeding DM Witt, T Delate, DA Garcia, NP Clark, EM Hylek, W Ageno, F Dentali, ... Archives of internal medicine 172 (19), 1484-1491, 2012 | 282 | 2012 |
| Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trial MA Crowther, W Ageno, D Garcia, L Wang, DM Witt, NP Clark, ... Annals of internal medicine 150 (5), 293-300, 2009 | 212 | 2009 |
| Guidance for the practical management of warfarin therapy in the treatment of venous thromboembolism DM Witt, NP Clark, S Kaatz, T Schnurr, JE Ansell Journal of thrombosis and thrombolysis 41, 187-205, 2016 | 197 | 2016 |
| Outcomes and predictors of very stable INR control during chronic anticoagulation therapy DM Witt, T Delate, NP Clark, C Martell, T Tran, MA Crowther, DA Garcia, ... Blood, The Journal of the American Society of Hematology 114 (5), 952-956, 2009 | 141 | 2009 |
| Bleeding, recurrent venous thromboembolism, and mortality risks during warfarin interruption for invasive procedures NP Clark, DM Witt, LE Davies, EM Saito, KH McCool, JD Douketis, ... JAMA internal medicine 175 (7), 1163-1168, 2015 | 140 | 2015 |
| Twelve‐month outcomes and predictors of very stable INR control in prevalent warfarin users DM Witt, T Delate, NP Clark, C Martell, T Tran, MA Crowther, DA Garcia, ... Journal of Thrombosis and Haemostasis 8 (4), 744-749, 2010 | 110 | 2010 |
| Low-molecular-weight heparin use in the obese, elderly, and in renal insufficiency NP Clark Thrombosis research 123, S58-S61, 2008 | 97 | 2008 |
| Incidence and predictors of bleeding or thrombosis after polypectomy in patients receiving and not receiving anticoagulation therapy DM Witt, T Delate, KH McCool, MB Dowd, NP Clark, MA Crowther, ... Journal of Thrombosis and Haemostasis 7 (12), 1982-1989, 2009 | 96 | 2009 |
| Natural history of mesenteric venous thrombosis in patients treated with vitamin K antagonists F Dentali, W Ageno, D Witt, A Malato, N Clark, D Garcia, K McCool, ... Thrombosis and haemostasis 102 (09), 501-504, 2009 | 88 | 2009 |
| The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) study for patients on a direct oral anticoagulant who need an elective surgery or procedure: design and rationale JD Douketis, AC Spyropoulos, JM Anderson, DM Arnold, SM Bates, ... Thrombosis and haemostasis 117 (12), 2415-2424, 2017 | 87 | 2017 |
| Brand name versus generic warfarin: a systematic review of the literature F Dentali, MP Donadini, N Clark, MA Crowther, D Garcia, E Hylek, DM Witt, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 31 (4 …, 2011 | 74 | 2011 |
| Warfarin interactions with antibiotics in the ambulatory care setting NP Clark, T Delate, CS Riggs, DM Witt, EM Hylek, DA Garcia, W Ageno, ... JAMA internal medicine 174 (3), 409-416, 2014 | 72 | 2014 |
| Thromboembolic prevention and anticoagulant therapy during the COVID-19 pandemic: updated clinical guidance from the anticoagulation forum GD Barnes, A Burnett, A Allen, J Ansell, M Blumenstein, NP Clark, ... Journal of thrombosis and thrombolysis 54 (2), 197-210, 2022 | 56 | 2022 |
| Effect of warfarin on intracranial hemorrhage incidence and fatal outcomes DM Witt, T Delate, EM Hylek, NP Clark, MA Crowther, F Dentali, W Ageno, ... Thrombosis research 132 (6), 770-775, 2013 | 51 | 2013 |
| Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study Warfarin‐Associated Research Projects and Other Endeavors (WARPED) Consortium Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 28 (8 …, 2008 | 46 | 2008 |